San Mateo County Logo
File #: 18-247    Version: 1 Name:
Type: Resolution Status: Passed
File created: 3/7/2018 Departments: HEALTH
On agenda: 3/27/2018 Final action: 3/27/2018
Title: Adopt a resolution authorizing the County Purchasing Agent to continue to issue purchase orders to Priority Healthcare, dba Curascript Specialty Distribution, to provide intrauterine and implantable prescription devices, increasing the amount by $500,000 in an amount not to exceed $1,000,000.
Attachments: 1. 20180327_r_Priority Health Care.pdf
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
No records to display.
Special Notice / Hearing: None__
Vote Required: Majority

To: Honorable Board of Supervisors
From: Louise F. Rogers, Chief, Health System
Chester J. Kunnappilly, MD, Chief Executive Officer, San Mateo Medical Center
Subject: Issuance of Purchase Orders to Priority Healthcare dba Curascript Specialty Distribution

RECOMMENDATION:
title
Adopt a resolution authorizing the County Purchasing Agent to continue to issue purchase orders to Priority Healthcare, dba Curascript Specialty Distribution, to provide intrauterine and implantable prescription devices, increasing the amount by $500,000 in an amount not to exceed $1,000,000.

body
BACKGROUND:
San Mateo Medical Center (SMMC) pharmacy has been purchasing intrauterine and implantable prescription devices for many years through vendor agreements with Priority Healthcare dba Curascript Specialty Distribution (Curascript). On May 24, 2016, your Board approved a Resolution waiving the Request for Bid process because Curascript is a sole source for the Nexplanon contraceptive devices. In addition, your Board authorized the County's Purchasing Agent to issue a vendor agreement for the term June 1, 2016 to May 31, 2019, in an amount not to exceed $500,000 as part of the County's commitment to women's health.

DISCUSSION:
SMMC's pharmacy underestimated the number of patients who need the Nexplanon contraceptive devices. Although the pharmacy's original projections were based on historical data, the device has proved significantly more popular than expected due to its effectiveness and long life (i.e. 3 years).

To date, SMMC has purchased $455,000 of these devices under the existing vendor agreement, with more than a year remaining on the agreement. In order to meet the increased demand of providers prescribing these devices to patients, SMMC is now requesting that your Board authorize an increase of $500,000 in an amount not to exceed $1,000,000 for the remainder of the term.

The resolution has bee...

Click here for full text